GlaxoSmithKline (GSK) has received approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for its regulatory ...

GlaxoSmithKline (GB:GSK) has released an update.Don't Miss our Black Friday Offers:Unlock your investing potential with TipRanks Premium - Now ...

In this Q&A, He discussed Boehringer's investments in AI as well as areas where the technology could deliver greater value for pharma.

New research led by the University of Washington found that wildfire smoke is especially hazardous to people's memory health. An analysis of the health care records of 1.2 million Southern California ...

Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, recently partnered with Solu Therapeutics (Solu) and is pleased to announce the ...

Jefferies analyst Peter Welford maintained a Hold rating on Genmab A/S (0MGB – Research Report) today and set a price target of DKK1,650.00.

Advancements and Projections in the Global Pulmonary Arterial Hypertension Market: Insights, Trends, Opportunities, and ...

In a randomized controlled trial of people with type 2 diabetes, albuminuria, and estimated glomerular filtration rate (eGFR) between 25 and 75 mL/min/1.73 m2, subcutaneous semaglutide reduced the ...

Growing Adoption of Plant-based and Organic Dietary Supplements among Consumers Contributing to <a target=_blank href= ...

In September, 2022, Corium, Inc., a fully-integrated biopharmaceutical company, announced the launch of ADLARITY (donepezil transdermal system) in the U.S. for the treatment of patients with mild, ...

MDCX READ THE FULL V.MDCX RESEARCH REPORT IPO in U.S. Provides Additional Funding & Common Stock that Trades on Nasdaq On ...

The US Food and Drug Administration (FDA) is expected to make a Prescription Drug User Fee Act (PDUFA) decision by mid-2025.